Delivery Order SPE2DB20D3111-SPE2DB25FA9KH
Award Date 9/11/25
Potential Completion Date 9/12/25
Potential Value $1.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Atropine 1 mg/ml vials. This firm fixed-price delivery order, valued at $4,324.70, is set to be completed by August 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded without any set-aside designation, reflecting AmerisourceBergen's established capability to meet federal...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Atropine 1 mg/mL vials. This firm fixed price delivery order, valued at $1,339.21, represents a non-competitive award and is set to be completed by July 28, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,269.70 to AmerisourceBergen Drug Corp for the supply of Atropine 0.4 mg/mL vials. This award, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, utilizes a firm fixed-price delivery order contract type with no set-aside designation. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, reflecting the company's role as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,799.30 to AmerisourceBergen Drug Corp for Atropine 0.4 mg/mL vials, with an ultimate completion date of September 10, 2025. This competitively awarded, firm fixed-price contract involves no set-aside provisions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Atropine 1 mg/mL vials under a firm fixed-price contract valued at $2,111.43. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $2,849.28 to AmerisourceBergen Drug Corp on July 22, 2025, for Atropine 0.4 mg/mL vials. This is a firm fixed price delivery order with no set-aside designation, issued as a competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract specifies performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025....
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 10, 2025, for the supply of Atropine 1 mg/mL vials valued at $3,459.76. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of August 11, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a $4,976.44 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Atropine 0.4 mg/ml vials. This firm fixed-price contract, which is expected to be completed by August 21, 2025, represents a routine pharmaceutical procurement supporting federal medical supply needs. The award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal procurement standards...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Atropine 1 mg/ml vials. This firm fixed-price delivery order, valued at $6,487.05, represents a non-competitive award with an ultimate completion date of August 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. The delivery...
- The Defense Logistics Agency awarded a $1,577.41 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Atropine 0.4 mg/ml in vial format. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract is set to be completed by August 8, 2025, with performance occurring at the...